Assignee
TRANSLATIONAL DRUG DEV LLC
US·13 granted patents·4 pending applications·11 citations·filing 2014–2022
Top patents by PatentIndex Score
17 records- 0185US11555039B2Amide compounds as kinase inhibitors, compositions and methods of treatmentTRANSLATIONAL DRUG DEV LLC·Filed 2020·Granted Jan 17, 2023·1 cites·19 claims
- 0284US11236052B2Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylaseTRANSLATIONAL DRUG DEV LLC·Filed 2018·Granted Feb 1, 2022·4 cites·20 claims
- 0384US10392402B2Heterocyclic compounds as kinase inhibitorsTRANSLATIONAL DRUG DEV LLC·Filed 2016·Granted Aug 27, 2019·4 cites·20 claims
- 0476US10633393B2Heterocyclic compounds as kinase inhibitorsTRANSLATIONAL DRUG DEV LLC·Filed 2019·Granted Apr 28, 2020·1 cites·24 claims
- 0575US11420947B2(S)-n-hydroxy-2-(2-(4-methoxyphenyl)butanamido)thiazole-5-carboxamide and pharmaceutically acceptable salts thereofTRANSLATIONAL DRUG DEV LLC·Filed 2021·Granted Aug 23, 2022·0 cites·8 claims
- 0674US10131654B2Pyrazole compounds and methods of use thereofTRANSLATIONAL DRUG DEV LLC·Filed 2014·Granted Nov 20, 2018·1 cites·18 claims
- 0770US2023143583A1Amide compounds as kinase inhibitors, compositions and methods of treatmentTRANSLATIONAL DRUG DEV LLC·Filed 2022·Application pending·0 cites
- 0869US11780816B2Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylaseTRANSLATIONAL DRUG DEV LLC·Filed 2022·Granted Oct 10, 2023·0 cites·20 claims
- 0969US2022402884A1(s)-n-hydroxy-2-(2-(4-methoxyphenyl)butanamido)thiazole-5-carboxamide and pharmaceutically acceptable salts thereofTRANSLATIONAL DRUG DEV LLC·Filed 2022·Application pending·0 cites
- 1063US10590088B24-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereofTRANSLATIONAL DRUG DEV LLC·Filed 2018·Granted Mar 17, 2020·0 cites·17 claims
- 1160US12076401B2Benzamide and active compound compositions and methods of useTRANSLATIONAL DRUG DEV LLC·Filed 2020·Granted Sep 3, 2024·0 cites·20 claims
- 1260US10584119B2Pyrazole compounds and methods of use thereofTRANSLATIONAL DRUG DEV LLC·Filed 2018·Granted Mar 10, 2020·0 cites·20 claims
- 1357US10807966B2Heterocyclic compounds as kinase inhibitorsTRANSLATIONAL DRUG DEV LLC·Filed 2017·Granted Oct 20, 2020·0 cites·9 claims
- 1457US10780080B2Benzamide and active compound compositions and methods of useTRANSLATIONAL DRUG DEV LLC·Filed 2017·Granted Sep 22, 2020·0 cites·8 claims
- 1555US10881733B2Benzamide and active compound compositions and methods of useTRANSLATIONAL DRUG DEV LLC·Filed 2016·Granted Jan 5, 2021·0 cites·17 claims
- 1651US2022184040A1Method of treating malignant rhabdoid tumor of the ovary and small cell cancer of the ovary of the hypercalcemic typeTRANSLATIONAL DRUG DEV LLC·Filed 2020·Application pending·0 cites
- 1737US2019040017A1Aminobenzimidazole derivativesTRANSLATIONAL DRUG DEV LLC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →